Rigel Pharmaceuticals, Inc.RIGLNASDAQ
LOADING
|||
| Metric | Dec 20 | Dec 21 | Dec 22 | Dec 23 | Dec 24 |
|---|---|---|---|---|---|
| Revenue | 109 | 149↑37.4% | 120↓19.4% | 117↓2.8% | 179↑53.4% |
| Gross Profit | 108 | 148↑37.5% | 118↓20.0% | 110↓7.4% | 161↑46.3% |
| Operating Income | -29 | -12↑56.9% | -56↓344.5% | -20↑63.1% | 24↑218.1% |
| Net Income | -30 | -18↑39.8% | -59↓227.0% | -25↑57.2% | 17↑169.7% |
| EBITDA | -28 | -11↑59.2% | -54↓377.3% | -17↑68.5% | 29↑267.9% |
| EPS Diluted | -1.80 | -1.10↑38.9% | -3.40↓209.1% | -1.44↑57.6% | 0.99↑168.7% |